Pioglitazone
Product Images NDC 70934-619

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 70934-619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 619 30 Master Bottle Label Approval Rev A 07 20)

Label (70934 619 30 Master Bottle Label Approval   Rev A 07 20)
This is a medication label for Pioglitazone, an oral medication used to help control blood sugar levels in people with type 2 diabetes. The label includes information on the tablet's strength (15mg), dosage form (tablet), and National Drug Code (NDC) which identifies the medication. The label also notes that the medication is repackaged by a company called Noctind ramacstcas. However, it is not clear what the remaining text is referring to as it is not readable and appears to be a result of error.*
FDA Label Image

Chemical Structure (Image 1)

FDA Label Image

Figure 1 (Image 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.